Colchicine has Dose-Dependent Therapeutic Effects in a LPS-Induced Experimental Endotoxemia Model

Area of Science:

• Pharmacology
• Immunology
• Toxicology

Background:

• Colchicine, an ancient anti-inflammatory drug, carries risks due to toxicity.
• Determining the appropriate dosage is crucial for effective and safe therapeutic use.

Purpose of the Study:

• To evaluate the anti-inflammatory effects of three different colchicine doses (0.5, 1, and 5 mg/kg).
• To investigate colchicine's impact on cytokines, mesenteric blood flow, and tissue damage in an LPS-induced endotoxemia model.

Main Methods:

• An experimental endotoxemia model was established using 1 mg/kg LPS injection.
• The effects of colchicine at 0.5, 1, and 5 mg/kg were assessed on pro-inflammatory cytokines (IL-1β, TNF-α, IL-8, IL-17), mesenteric artery blood flow, and histopathological damage.

Main Results:

• A 1 mg/kg dose of colchicine significantly reduced pro-inflammatory cytokines and attenuated liver and spleen tissue damage.
• The 0.5 mg/kg dose did not effectively lower cytokine levels.
• The 5 mg/kg dose improved mesenteric blood flow but paradoxically increased cytokine levels.

Conclusions:

• The 1 mg/kg intraperitoneal dose of colchicine demonstrated significant anti-inflammatory effects and tissue protection in the endotoxemia model.
• This dose represents a potentially suitable option for anti-inflammatory treatment, balancing efficacy and safety.
• Further research into colchicine's dose-dependent effects is warranted.